Semintra Oral Solution for Cats (4 mg/mL)

Description

Semintra (telmisartan) is an oral solution specifically developed for cats to manage protein loss associated with chronic kidney disease (CKD). It belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). By blocking the effects of angiotensin II—a hormone that constricts blood vessels and increases blood pressure within the kidneys—Semintra helps to reduce systemic blood pressure and the amount of protein excreted in the urine (proteinuria). This targeted action supports kidney health and helps slow the progression of renal impairment in feline patients.

Key Information

• Active Ingredient: Telmisartan (4 mg/mL).

• Approved Species: Cat.

• Uses: Reduction of proteinuria associated with chronic kidney disease (CKD) and management of systemic hypertension (high blood pressure) in cats.

• Form: Oral solution.

• Route of Administration: Oral (can be administered directly into the mouth or with a small amount of food).

Prescription Required

Semintra is a prescription-only medication. A valid prescription from a licensed veterinarian is required for purchase. Professional monitoring is essential, as your veterinarian will need to perform regular blood pressure checks and blood work to monitor kidney values while your cat is receiving this treatment.